Aviana Molecular Technologies LLC Profile last edited on: 2/16/17
CAGE: 5EWE2
UEI: NX3XNGMMWJX7
Business Identifier: Rapid point of care diagnostic test for an STD 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 05
County: Delaware
Congr. District: 05
County: Delaware
Public Profile
Based on a highly manufacturable biosensor chip, Aviana Molecular Technologies LLC is developing a rapid point of care diagnostic test for an STD. .
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
10-14Revenue Range
1M-1.5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2020 | 2 | AF | $3,000,001 | |
| Project Title: Ruggedized Field Deployable Diagnostic for COVID-19 and other Emerging Infections using Advanced Surface Acoustic Wave Technology | ||||
| 2016 | 1 | NASA | $124,889 | |
| Project Title: Passive Wireless Sensor System for Space and Structural Health Monitoring | ||||
Key People / Management
Vanaja Ragavan -- CEO
Arthur Weeks
Arthur Weeks
Company News
There are no news available.
